<DOC>
	<DOCNO>NCT01920022</DOCNO>
	<brief_summary>Women abortion high risk subsequent unintended pregnancy repeat abortion . Clearly , encourage contraceptive use abortion high priority . Long act reversible contraceptive ( LARCs , Implants intrauterine contraception ) effective method help woman avoid repeat unwanted pregnancy abortion . Studies surgical abortion patient , show `` quickstart '' LARC - i.e. , insert surgical procedure - associate substantially great use method six month later require woman return later get device . However , today majority woman choose medical abortion . The clinical routine insert LARCs follow 2 3 week abortion treatment . Frequently woman choose part abortion treatment home return follow . Thus , possibility quick start contraceptive method medical abortion would major advantage especially could do time administration mifepristone .</brief_summary>
	<brief_title>Quickstart Nexplanon® Medical Abortion</brief_title>
	<detailed_description />
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<criteria>woman opt medical abortion post abortion Nexplanon contraindicate medical abortion Nexplanon ( accord SMPc ) gestational length include 63 day ( determined ultrasonography ) able willing provide inform consent unwilling participate , unable communicate Swedish English minor ( i.e . woman &lt; 18 year age ) , contraindication Nexplanon® woman pathological pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>medical abortion</keyword>
	<keyword>postabortion contraception</keyword>
	<keyword>LARC</keyword>
	<keyword>Nexplanon</keyword>
	<keyword>subdermal contraceptive implant</keyword>
</DOC>